TherOptix is an early-stage biopharmaceutical company focused on optimizing therapeutic benefit and clinical outcomes by delivering controlled, modifiable drug concentrations through contact lens to the front and/or back of the eye. The innovative, non-invasive technology platform enables clinically impactful therapeutic delivery.
TherOptix reposted this
OIS contributor, Bindu Manne interviews veteran OIS attendee, Monty Montoya CEO of TherOptix, who is looking forward to sharing data early next year and ramping up to raise $8 million in a Series A round. #OIS #OISXIII #Ophthalmology #TherOptix